e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Microbiology and treatment of bronchiectasis and exacerbations of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Resolution of isolated compared to recurrent COPD exacerbations
R. Baghai-Ravary, J. Quint, J. Goldring, J. Hurst, G. Donaldson, J. Wedzicha (London, United Kingdom)
Source:
Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Session:
Microbiology and treatment of bronchiectasis and exacerbations of COPD
Session type:
E-Communication Session
Number:
256
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Baghai-Ravary, J. Quint, J. Goldring, J. Hurst, G. Donaldson, J. Wedzicha (London, United Kingdom). Resolution of isolated compared to recurrent COPD exacerbations. Eur Respir J 2008; 32: Suppl. 52, 256
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Management of acute COPD exacerbations
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013
Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Source: Eur Respir J 2013; 41: 993-995
Year: 2013
Characterization of readmissions in patients hospitalized with COPD exacerbation
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Management of COPD exacerbations
Source: ERS Lung Science Conference 2019
Year: 2019
Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Treatment of infection in COPD exacerbations
Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases
Year: 2014
Predictors of exacerbations of COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 284s
Year: 2005
Bacterial infections in patients with acute exacerbations of COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004
Quantification of severity of the acute exacerbation in hospitalized COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 559s
Year: 2003
Impact of moderate and severe exacerbations in severe COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis
Source: International Congress 2016 – Dealing with the complexity of critically-ill patients
Year: 2016
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013
Effect of lower airway bacterial colonisation on time to acute exacerbation in patients with COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Do patients with recurrent exacerbations of COPD requiring NIV receive higher pressures than those that are NIV naive?
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013
Determinants of discharge treatment after hospitalization for an acute exacerbation of COPD
Source: Annual Congress 2007 - Treatment and care of COPD
Year: 2007
Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD.
Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes
Year: 2017
Microorganisms isolated in COPD patients hospitalised for acute exacerbations and their clinical correlations
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept